A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.

Current Medical Research and Opinion
D E BarnardoJ T Wright

Abstract

In a double-blind trial in 26 patients with symptomatic gastro-oesophageal reflux, the alginate/effervescent/antacid compound 'Gaviscon' was compared with antacid containing placebo similarly formulated. Retrosternal pain after meals and at night was significantly reduced whilst patients were taking 'Gaviscon' and the beneficial effects lasted for many weeks after discontinuation of the active preparation.

References

Jan 26, 1974·Lancet·C Stanciu, J R Bennett
Jan 1, 1972·The Journal of Clinical Pharmacology and New Drugs·G L BeckloffP Shiverdecker
Jan 1, 1972·Current Medical Research and Opinion·M Beeley, J O Warner
Jul 1, 1972·Journal of the American Geriatrics Society·G McHardy, L Balart
Sep 1, 1970·Thorax·A S WardJ L Collis

❮ Previous
Next ❯

Citations

Oct 1, 1987·Baillière's Clinical Gastroenterology·G N Tytgat, C Y Nio
Jun 10, 2000·Alimentary Pharmacology & Therapeutics·K G MandelH I Jacoby
Oct 1, 1993·Journal of Internal Medicine·G Bianchi Porro, F Pace
Dec 1, 1979·Australian Paediatric Journal·J A Keipert
Jul 3, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Daniel Sifrim, Roberto Penagini
Sep 28, 2016·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·D A LeimanJ D Lewis
Mar 16, 2006·European Journal of Gastroenterology & Hepatology·Henry CohenUNKNOWN Latin-American GORD Consensus Group
Apr 5, 2017·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·D A LeimanJ D Lewis
Aug 1, 1997·Scandinavian Journal of Gastroenterology·T Havelund, C Aalykke
Dec 1, 1990·Alimentary Pharmacology & Therapeutics·J R LambertJ G Chan
Feb 11, 1998·The Medical Clinics of North America·M L Borum

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.